Matches in SemOpenAlex for { <https://semopenalex.org/work/W4320492041> ?p ?o ?g. }
- W4320492041 endingPage "593" @default.
- W4320492041 startingPage "593" @default.
- W4320492041 abstract "Flavonoids exert many beneficial properties, such as anticancer activity. They were found to have chemopreventive effects hindering carcinogenesis, and also being able to affect processes important for cancer cell pathophysiology inhibiting its growth or promoting cell death. There are also reports on the chemosensitizing properties of flavonoids, which indicate that they could be used as a support of anticancer therapy. It gives promise for a novel therapeutic approach in tumors characterized by ineffective treatment, such as high-grade gliomas. The research was conducted on the in vitro culture of human SW1783 anaplastic astrocytoma cells incubated with neobavaisoflavone (NEO), doxorubicin, etoposide, and their combinations with NEO. The analyses involved the WST-1 cell viability assay and image cytometry techniques including cell count assay, Annexin V assay, the evaluation of mitochondrial membrane potential, and the cell-cycle phase distribution. We found that NEO affects the activity of doxorubicin and etoposide by reducing the viability of SW1783 cells. The combination of NEO and etoposide caused an increase in the apoptotic and low mitochondrial membrane potential subpopulations of SW1783 cells. Changes in the cell cycle were observed in all combined treatments. These findings indicate a potential chemosensitizing effect exerted by NEO." @default.
- W4320492041 created "2023-02-14" @default.
- W4320492041 creator A5013614260 @default.
- W4320492041 creator A5028071209 @default.
- W4320492041 creator A5034600401 @default.
- W4320492041 creator A5053419079 @default.
- W4320492041 creator A5060155673 @default.
- W4320492041 creator A5068203931 @default.
- W4320492041 date "2023-02-12" @default.
- W4320492041 modified "2023-09-30" @default.
- W4320492041 title "Evaluation of Possible Neobavaisoflavone Chemosensitizing Properties towards Doxorubicin and Etoposide in SW1783 Anaplastic Astrocytoma Cells" @default.
- W4320492041 cites W1993636025 @default.
- W4320492041 cites W1999389237 @default.
- W4320492041 cites W2002710196 @default.
- W4320492041 cites W2005036156 @default.
- W4320492041 cites W2014014132 @default.
- W4320492041 cites W2026021432 @default.
- W4320492041 cites W2036879539 @default.
- W4320492041 cites W2038069692 @default.
- W4320492041 cites W2051762732 @default.
- W4320492041 cites W2060708275 @default.
- W4320492041 cites W2071246885 @default.
- W4320492041 cites W2081215365 @default.
- W4320492041 cites W2092030031 @default.
- W4320492041 cites W2096287682 @default.
- W4320492041 cites W2124081909 @default.
- W4320492041 cites W2152793164 @default.
- W4320492041 cites W2157965986 @default.
- W4320492041 cites W2158025958 @default.
- W4320492041 cites W2166896446 @default.
- W4320492041 cites W2170233592 @default.
- W4320492041 cites W2270798386 @default.
- W4320492041 cites W2315485027 @default.
- W4320492041 cites W2340445357 @default.
- W4320492041 cites W2558206899 @default.
- W4320492041 cites W2600452401 @default.
- W4320492041 cites W2695753348 @default.
- W4320492041 cites W2772174090 @default.
- W4320492041 cites W2772877568 @default.
- W4320492041 cites W2804017836 @default.
- W4320492041 cites W2884687648 @default.
- W4320492041 cites W2892821207 @default.
- W4320492041 cites W2899402308 @default.
- W4320492041 cites W2902395974 @default.
- W4320492041 cites W2906146136 @default.
- W4320492041 cites W2907688525 @default.
- W4320492041 cites W2911906785 @default.
- W4320492041 cites W2914241029 @default.
- W4320492041 cites W2965889830 @default.
- W4320492041 cites W3005533031 @default.
- W4320492041 cites W3009553591 @default.
- W4320492041 cites W3012638502 @default.
- W4320492041 cites W3035844357 @default.
- W4320492041 cites W3092018313 @default.
- W4320492041 cites W3100994999 @default.
- W4320492041 cites W3112385740 @default.
- W4320492041 cites W3117655623 @default.
- W4320492041 cites W3134891916 @default.
- W4320492041 cites W3146132470 @default.
- W4320492041 cites W3162375438 @default.
- W4320492041 cites W3163887519 @default.
- W4320492041 cites W3169797282 @default.
- W4320492041 cites W3170024122 @default.
- W4320492041 cites W3183903830 @default.
- W4320492041 cites W3193929510 @default.
- W4320492041 cites W3198894769 @default.
- W4320492041 cites W3208076236 @default.
- W4320492041 cites W4220702628 @default.
- W4320492041 cites W4280537132 @default.
- W4320492041 cites W1851620310 @default.
- W4320492041 doi "https://doi.org/10.3390/cells12040593" @default.
- W4320492041 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36831260" @default.
- W4320492041 hasPublicationYear "2023" @default.
- W4320492041 type Work @default.
- W4320492041 citedByCount "0" @default.
- W4320492041 crossrefType "journal-article" @default.
- W4320492041 hasAuthorship W4320492041A5013614260 @default.
- W4320492041 hasAuthorship W4320492041A5028071209 @default.
- W4320492041 hasAuthorship W4320492041A5034600401 @default.
- W4320492041 hasAuthorship W4320492041A5053419079 @default.
- W4320492041 hasAuthorship W4320492041A5060155673 @default.
- W4320492041 hasAuthorship W4320492041A5068203931 @default.
- W4320492041 hasBestOaLocation W43204920411 @default.
- W4320492041 hasConcept C126322002 @default.
- W4320492041 hasConcept C1491633281 @default.
- W4320492041 hasConcept C185592680 @default.
- W4320492041 hasConcept C190283241 @default.
- W4320492041 hasConcept C2776694085 @default.
- W4320492041 hasConcept C2778119113 @default.
- W4320492041 hasConcept C2781303535 @default.
- W4320492041 hasConcept C29537977 @default.
- W4320492041 hasConcept C31573885 @default.
- W4320492041 hasConcept C502942594 @default.
- W4320492041 hasConcept C53227056 @default.
- W4320492041 hasConcept C55493867 @default.
- W4320492041 hasConcept C62112901 @default.
- W4320492041 hasConcept C71924100 @default.
- W4320492041 hasConcept C86803240 @default.